BlackRock Investment Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$14K Hold
13
﹤0.01% 3491
2016
Q3
$5K Buy
13
+2
+18% +$816 ﹤0.01% 3789
2016
Q2
$5K Hold
11
﹤0.01% 3859
2016
Q1
$5K Hold
11
﹤0.01% 3826
2015
Q4
$7K Hold
11
﹤0.01% 3796
2015
Q3
$10K Hold
11
﹤0.01% 3697
2015
Q2
$12K Buy
11
+3
+38% +$3.52K ﹤0.01% 3654
2015
Q1
$12K Hold
8
﹤0.01% 3598
2014
Q4
$11K Sell
8
-1
-11% -$1.45K ﹤0.01% 3656
2014
Q3
$11K Buy
9
+1
+13% +$1.44K ﹤0.01% 3643
2014
Q2
$15K Sell
8
-81
-91% -$108K ﹤0.01% 3499
2014
Q1
$144K Buy
89
+9
+11% +$18.8K ﹤0.01% 3269
2013
Q4
$103K Buy
80
+33
+70% +$52.7K ﹤0.01% 3275
2013
Q3
$94K Buy
+47
New +$87.4K ﹤0.01% 3237

Other funds holding HSTO

BlackRock Investment Management's HSTO Position: Q4 2016 in Review

BlackRock Investment Management held its Histogen Inc. Common Stock (HSTO) position steady in Q4 2016 at 13 shares worth $14K. The position accounts for ﹤0.01% of the portfolio, ranked #3491.

BlackRock Investment Management first reported a position in HSTO in Q3 2013 and has held it in 14 quarters since. The position peaked at $144K in Q1 2014. 41 funds tracked by Wall St. Rank hold HSTO as of Q4 2016.

  • BlackRock Investment Management held 13 shares of Histogen Inc. Common Stock worth $14K as of Q4 2016.
  • BlackRock Investment Management left its Histogen Inc. Common Stock share count unchanged in Q4 2016.
  • Histogen Inc. Common Stock made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #3491 holding.
  • BlackRock Investment Management first reported a position in Histogen Inc. Common Stock in Q3 2013 and has held it in 14 quarters since.
  • BlackRock Investment Management's Histogen Inc. Common Stock position peaked at $144K in Q1 2014.
  • 41 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.